CAR T-cells targeting the epidermal growth factor receptor (EGFR) 806 epitope that is uniquely expressed on the surface of tumor cells can effectively eradicate glioblastoma (GBM) cells while sparing EGFR-expressing human fetal astrocytes (23). This evidence concerns the gene EGFR and neoplasm.